NewsBiogen Joins Forces with City Therapeutics to Develop Novel RNAi TherapiesByRidhi RastogiMay 28, 20250Comments
NewsSamsung Bioepis and Organon’s Hadlima (Biosimilar, Humira) Receives the US FDA’s Interchangeability Designation for All PresentationsByRidhi RastogiMay 28, 20250Comments
NewsAnX Robotica’s MotiliCap and MotiliScan Receive the US FDA’s 510(k) Clearance for GI Motility MonitoringByRidhi RastogiMay 28, 20250Comments
NewsGRIN Therapeutics Collaborates with Angelini Pharma to Co-Develop and Commercialize Radiprodil for Neurological DisordersByRidhi RastogiMay 28, 20250Comments
NewsEli Lilly to Acquire SiteOne Therapeutics for ~$1B, Strengthening its Pain PipelineByRidhi RastogiMay 28, 20250Comments
NewsAstraZeneca Reports the CHMP’s Positive Opinion for Perioperative Imfinzi to Treat Muscle-Invasive Bladder Cancer (MIBC)ByRidhi RastogiMay 27, 20250Comments
NewsRemeGen’s Telitacicept Receives the NMPA’s Approval for Generalized Myasthenia Gravis (gMG)ByRidhi RastogiMay 27, 20250Comments
